The Zero Residual™ concept ensures precise dosing and control throughout the procedure, prioritizing safety. It allows users to prefill syringes air-free and eliminates the risk of silicone oil contamination, offering a silicone oil-free preparation. With a low residual volume, it maximizes medication use and reduces waste.

Currently, ophthalmologists use Zero Residual™ primarily for anti-VEGF injections to treat wet-AMD, DME, and related ocular diseases. Ongoing discussions with healthcare professionals aim to further enhance the concept.

Consistent delivery into the suprachoroidal space

Surpalis is a precision injection concept  purpose-built for the suprachoroidal space. 

Combining the existing Zero Residual™ system with a tool optimised for suprachoroidal access, Surpalis gives practitioners a reproducible, accurate, and safe method for consistently delivering medicine directly into the suprachoroidal space. With zero compromise on dose integrity.

Reproducible

Reproducible technique to ensure consistent delivery into the suprachoroidal space

Accurate dosing

The Zero Residual concept ensures precise dosing levels

Minimally invasive

Designed for office-based clinical use